Abstract
We have previously demonstrated that murine colon tumor cells transfected with the gene coding for the hemagglutination antigen (HA) of influenza virus acquire an inherent immunogenicity, fail to grow in syngeneic mice, and demonstrate an ability to cross-protect against a challenge with parental nontransfected cells. In the present study the immunogenic potential of HA-transfected cells correlated with cell-surface HA expression, as measured both by a fluorescence-activated cell sorter and by radiolabeled antibody binding. HA-transfected immunogenic cells had a median lethal dose (LD50) that was 10000-fold greater than that of nontransfected cells. Most importantly this study demonstrated that HA-transfected cells retained their immunogenicity after X-irradiation with 12000 rad. This characteristic makes their potential usefulness in treating human neoplasia more plausible.
Keywords: Influenza, Influenza Virus, Cell Sorter, Antibody Binding, Lethal Dose
References
- 1.Boon T. Antigenic tumor cell variants obtained with mutagens. Adv Cancer Res. 1983;39:121. doi: 10.1016/s0065-230x(08)61034-9. [DOI] [PubMed] [Google Scholar]
- 2.Boone CW, Blackman K. Augmented immunogenicity of tumor cell homogenates infected with influenza virus. Cancer Res. 1972;32:1018. [PubMed] [Google Scholar]
- 3.Brattain MG, Strobel-Stevens J, Find D, Webb M, Sarrif AM. Establishment of mouse colonic carcinoma cell lines with different metastatic properties. Cancer Res. 1980;40:2142. [PubMed] [Google Scholar]
- 4.Fearon ER, Itaya T, Hunt B, Vogelstein B, Frost P. The induction of immunogenic tumor variants by transfection with a foreign gene. Cancer Res. 1988;38:2975. [PubMed] [Google Scholar]
- 5.Frost P, Kerbel R, Bauer E, Tartamella-Biondo R, Cefalu W. Mutagen treatment as a means for selecting immunogenic variants from otherwise poorly immunogenic malignant murine tumors. Cancer Res. 1983;43:125. [PubMed] [Google Scholar]
- 6.Hamaoka T, Fujiwara H, Teshima K, Aoki H, Yamamoto H, Kitagawa M. Regulatory function of hapten-reactive helper and suppressor T lymphocytes. III. Amplification of generation of tumor-specific cytotoxic effector T lymphocytes by suppressor T cell-depleted hapten reactive T lymphocytes. J Exp Med. 1979;149:185. doi: 10.1084/jem.149.1.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Hosokawa M, Okayasu T, Ikeda K, Katoh H, Susuki H, Kobayashi I. Alteration of immunogenicity of xenogenized tumor cells in syngeneic rats by the immune response to virus-associated antigens produced on immunizing cells. Cancer Res. 1983;43:2301. [PubMed] [Google Scholar]
- 8.Itaya T, Yamagiwa S, Okada AF, Oikawa T, Kuzamaki N, Takeichi N, Hosokawa M, Kobayashi H. Xenogenization of a mouse lung carcinoma (3LL) by transfection with an allogeneic class 1 major histocompatibility complex gene (h-2Ld) Cancer Res. 1987;47:3136. [PubMed] [Google Scholar]
- 9.Kerbel RS, Frost P, Carlow DA, Elliott BE. Possible epigenetic mechanisms of tumor progression: induction of high-frequency heritable but phenotypically unstable changes in the tumorigenic and metastatic properties of tumor cell populations by 5-azacytidine treatment. J Cell Physiol. 1984;3:87. doi: 10.1002/jcp.1041210411. [DOI] [PubMed] [Google Scholar]
- 10.Kobayashi H, Takeichi N, Kuzumaki N. Xenogenization of tumor cells in xenogenization of lymphocytes, erythroblasts, and tumor cells. Hokkaido Univ Med Libr Ser. 1978;10:117. [Google Scholar]
- 11.Lachman PJ, Sikora K. Coupling PPD to tumor cells enhances their antigenicity in BCG-primed mice. Nature. 1978;271:463. doi: 10.1038/271463a0. [DOI] [PubMed] [Google Scholar]
- 12.Lindenmann J, Klein PA. Increased immunogenicity of host cell antigen associated with influenza virus. J Exp Med. 1967;126:93. doi: 10.1084/jem.126.1.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Reed L, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg. 1938;27:493. [Google Scholar]
- 14.Sambrook J, Rogers L, White J, Gething MJ. Lines of BPV-transformed mouse cells that constitutively express influenza virus hemagglutinin. EMBO J. 1985;4:91. doi: 10.1002/j.1460-2075.1985.tb02322.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Sella A, Hunt B, Frost P. Mutagen induced Imm+ variants: The need for viable and cloned Imm+ variants for effective protection against a primary murine tumor and its metastases. Clin Exp Metastasis. 1989;7:97–105. doi: 10.1007/BF02057184. [DOI] [PubMed] [Google Scholar]
- 16.Yamaguchi H, Moriuchi T, Hosokawa M, Kobayashi H. Increased or decreased immunogenicity of tumor-associated antigen according to the amount of virus-associated antigen in rat tumor cells infected with Friend virus. Cancer Immunol Immunother. 1982;12:119. [Google Scholar]